Regarding ovarian cancer cells, roflumilast induces apoptosis and prevents tumor progression by activating the cAMP/PKA/CREB pathway and upregulating mitochondrial ferritin (FtMt) levels in the two types of cells (OVCAR3 and SKOV3) (55). Here, FTMT is linked to neoplasm.